Found 8 matching trials
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) PHASE2 The purpose of the study was to assess the effects of different doses of tr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) PHASE2 This clinical study was designed to evaluate the safety, tolerability, phar...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects PHASE1 The primary purpose of this study is to evaluate the effect of hepatic impa...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. PHASE1 The purpose of this study is to determine whether dosing tropifexor is safe...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis PHASE2 The purpose of this study was to assess the safety, tolerability, and effic...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea. PHASE2 The purpose of this study is to determine whether LJN452 improves the sympt...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. PHASE2 Randomized, double-blind, parallel-group, multicenter study to assess effic...
Show More Location
Gut PC Digestive Health Specialist
Learn More & Join Trial
A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients PHASE2 A multi-part study to assess safety, tolerability and efficacy of tropifexo...
Show More Location
Novartis Investigative Site
Learn More & Join Trial